The store will not work correctly when cookies are disabled.
1-(4-chlorophenyl)-N-cyclopropyl-1H-pyrrolo[2,3-b]pyridine-2-carboxamide
ID: ALA4745467
PubChem CID: 149589836
Max Phase: Preclinical
Molecular Formula: C17H14ClN3O
Molecular Weight: 311.77
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NC1CC1)c1cc2cccnc2n1-c1ccc(Cl)cc1
Standard InChI: InChI=1S/C17H14ClN3O/c18-12-3-7-14(8-4-12)21-15(17(22)20-13-5-6-13)10-11-2-1-9-19-16(11)21/h1-4,7-10,13H,5-6H2,(H,20,22)
Standard InChI Key: ZXRNVWPRRUTNLN-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
27.3869 -5.5098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3857 -6.3293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0938 -6.7383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0920 -5.1010 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.8006 -5.5062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8009 -6.3248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5795 -6.5776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0605 -5.9151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5791 -5.2531 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.8777 -5.9148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2861 -5.2070 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.8297 -4.4773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6304 -4.3082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8827 -3.5318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3355 -2.9237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5326 -3.0973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2840 -3.8736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5867 -2.1461 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
31.2866 -6.6224 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.1038 -6.6221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8106 -7.0273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8104 -6.2101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
8 10 1 0
10 11 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
9 12 1 0
15 18 1 0
10 19 1 0
19 20 1 0
21 20 1 0
22 21 1 0
20 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 311.77 | Molecular Weight (Monoisotopic): 311.0825 | AlogP: 3.57 | #Rotatable Bonds: 3 |
Polar Surface Area: 46.92 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.51 | CX LogP: 3.17 | CX LogD: 3.17 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.80 | Np Likeness Score: -1.69 |
References
1. Vadukoot AK,Sharma S,Aretz CD,Kumar S,Gautam N,Alnouti Y,Aldrich AL,Heim CE,Kielian T,Hopkins CR. (2020) Synthesis and SAR Studies of 1H-Pyrrolo[2,3-b]pyridine-2-carboxamides as Phosphodiesterase 4B (PDE4B) Inhibitors., 11 (10): [PMID:33062163] [10.1021/acsmedchemlett.9b00369] |